Telangiectasis: all 154 studies

Page 1 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and TelangiectasiasRecruitingNCT07793630Phase 4
• Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS TechniqueRecruitingNCT07678697Not applicable
• Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/2
• Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser TherapyRecruitingNCT07521462Not applicable
• The Effect of 16-week Dietary Intake of Food Supplements Containing Collagen and MSM on Facial Erythema and Other Skin ParametersNot yet recruitingNCT07345195Not applicable
• CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb TelangiectasiasNot yet recruitingNCT07073742Phase 2
• Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide RibosideNot yet recruitingNCT06324877Not applicable
• Quality of Life in Patients With Hemorrhagic TelangiectasiaEnrolling by invitationNCT06261333
• Comprehensive HHT Outcomes Registry of the United States (CHORUS)RecruitingNCT06259292
• Home-based Complex Intervention for Children With Ataxia TelangiectasiaRecruitingNCT05692622Not applicable
• Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic TelangiectasiaRecruitingNCT04469517
• Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic TelangiectasiaNot yet recruitingNCT03850730Phase 1/2
• Partial Breast Versus no Irradiation for Women With Early Breast CancerRecruitingNCT03646955Not applicable
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
• Case Notes Review on Patients With Hereditary Haemorrhagic TelangiectasiaRecruitingNCT00230685
• Molecular Studies on Hereditary Haemorrhagic Telangiectasia FamiliesRecruitingNCT00230620
• Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2CompletedNCT04729972Phase 2Results posted
• Skin Imaging to Inform Laser TreatmentsTerminatedNCT04336163Not applicableResults posted
• Timolol Gel for Epistaxis in Hereditary Hemorrhagic TelangiectasiaCompletedNCT04139018Phase 2Results posted
• Pomalidomide for the Treatment of Bleeding in HHTCompletedNCT03910244Phase 2Results posted
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol BCompletedNCT03319849Phase 3Results posted
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol ACompletedNCT03316300Phase 3Results posted
• Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)CompletedNCT03152019Phase 2Results posted
• Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)CompletedNCT03071965Phase 2Results posted
• Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia PatientsCompletedNCT02770807Phase 3Results posted
• A Clinical Evaluation of the Treatment of Spider Veins on the AnklesCompletedNCT02754479Not applicableResults posted
• Polidocanol Versus Glucose Treatment of Telangiectasia TrialCompletedNCT02657252Phase 4Results posted
• Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)CompletedNCT02638012Not applicableResults posted
• Intranasal Bevacizumab for HHT-Related EpistaxisCompletedNCT02389959Phase 4Results posted
• Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic TelangiectasiaTerminatedNCT02204371Phase 2Results posted
• Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of ConceptCompletedNCT01752049Phase 1/2Results posted
• Diet and Hereditary Haemorrhagic TelangiectasiaCompletedNCT01692015Not applicableResults posted
• Hereditary Haemorrhagic Telangiectasia Flight Safety StudyCompletedNCT01590121Results posted
• Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of CivatteCompletedNCT01491620Not applicableResults posted
• Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic TelangiectasiaCompletedNCT01408732Phase 1/2Results posted
• North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01408030Phase 2Results posted
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01402531Phase 2Results posted
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01397695Phase 2Results posted
• Treatment of Lower Extremity Spider Veins With Excel VCompletedNCT01362192Phase 4Results posted
• High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal TelangiectasiaCompletedNCT01205035Phase 2Results posted
• Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaTerminatedNCT00588146Phase 2Results posted
• Sirolimus Treatment in Pediatric Patients With Ataxia-TelangiectasiaCompletedNCT07820579Phase 2
• Brimonidine 0.33% for Rosacea-Related Facial ErythemaCompletedNCT07431476Phase 4
• Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and TelangiectasiasCompletedNCT06962813Not applicable
• Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With RosaceaCompletedNCT06582043Not applicable
• Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABHCompletedNCT06039124
• Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial IntelligenceCompletedNCT05978986Not applicable
• Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT DatabaseActive, not recruitingNCT05933330
• Lower Limb Sclerotherapy of Reticular Veins and TelangiectasiasCompletedNCT05860439
• Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.CompletedNCT05752253Not applicable
• Genotype-phenotype Association in Hereditary Hemorrhagic TelangiectasiaCompletedNCT05550376
• Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy SubjectsStatus unknownNCT05531890Phase 1
• Videoocular Assessment of Eye Movement Activity in an Ataxia TelangiectasiaCompletedNCT05471310
• Whole Body MRI for Cancer Surveillance in A-TCompletedNCT05252819
• Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic SclerodermaCompletedNCT05036200Not applicable
• A National Retrospective Population Based Cohort Study of the Natural History of Ataxia TelangiectasiaStatus unknownNCT04991701
• MBM-01 (Tempol) for the Treatment of Ataxia TelangiectasiaStatus unknownNCT04887311Phase 2
• NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia TelangiectasiaActive, not recruitingNCT04870866Phase 2
• Clinical Observation of Pulsed Dye Laser and Intense Pulsed Light in Treating Facial TelangiectasiaCompletedNCT04795310Not applicable
• Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus ErythematosusStatus unknownNCT04717583Not applicable
• Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT04646356Phase 2
• Neurofilament Light- Chain in Ataxia TelangiectasiaStatus unknownNCT04605523
• Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of AnaplerosisCompletedNCT04513002Phase 2
• Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland DysfunctionCompletedNCT04425551Not applicable
• D-OCT of Facial Telangiectasia Treated With IPLCompletedNCT04274842Not applicable
• Effects of Kinesio Taping Method on Functional Capacity and Quality of Life in Patients With Chronic Venous DiseaseCompletedNCT04148950Not applicable
• Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of TelangiectasiaCompletedNCT04132323Not applicable
• Treatment of Leukemia and Lymphoma in Children With Ataxia TelangiectasiaStatus unknownNCT04037189
• Laser Treatment Of Leg TelangiectasiasCompletedNCT04004728Not applicable
• Vitamin D and Hereditary Haemorrhagic TelangiectasiaStatus unknownNCT03981562Phase 2
• Effects of Vitamin B3 in Patients With Ataxia TelangiectasiaCompletedNCT03962114Phase 2
• Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver TransplantationCompletedNCT03942315
• Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT)CompletedNCT03940014
• Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHTActive, not recruitingNCT03841422
• Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease.CompletedNCT03695874
• Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)CompletedNCT03691142
• A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)CompletedNCT03669393Phase 2
• Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT03572556
• Nationwide Awareness Campaign and Call for Dental Screening for HHT in GermanyStatus unknownNCT03549949
• Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green LaserCompletedNCT03472859Not applicable
• Doxycycline for Hereditary Hemorrhagic TelangiectasiaCompletedNCT03397004Phase 2
• Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia TelangiectasiaStatus unknownNCT03357978Not applicable
• MacTel Laser StudyCompletedNCT03321916Not applicable
• MRA With Feraheme in HHTCompletedNCT02977637Phase 1
• Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHTStatus unknownNCT02963129Phase 3
• Graded TTCE for Post-Embolization PAVM MonitoringCompletedNCT02936349
• Octreotide in Patients With GI Bleeding Due to Rendu-Osler-WeberStatus unknownNCT02874326Phase 2
• Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)TerminatedNCT02857894
• Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial TelangiectasiasCompletedNCT02761174Phase 4
• Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneCompletedNCT02733679Phase 4
• Symptoms and Treatment Results in Hereditary Hemorrhagic TelangiectasiaCompletedNCT02690246
• Frequency of Common Medical Conditions in People With and Without HHTCompletedNCT02464644Not applicable
• Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow ObstructionStatus unknownNCT02458703Not applicable
• Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMsCompletedNCT02436213Not applicable
• Body Composition and Hormonal Status in Ataxia TelangiectasiaCompletedNCT02345200Not applicable
• Susceptibility to Infections in Ataxia TelangiectasiaCompletedNCT02345135Not applicable
• Pancreatic Cancer Screening of High-Risk Individuals in ArkansasWithdrawnNCT02309632Not applicable
• Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I StudyCompletedNCT02287558Phase 1
• Ultherapy for the Treatment of Spider Veins on the LegsCompletedNCT02286804Not applicable
• Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-TCompletedNCT02285348Not applicable

← Telangiectasis overview